February 2026 proved to be a pivotal month for the oncology landscape, as the FDA green-lit several therapies targeting some ...
West Yorkshire health leaders welcome new national cancer plan but warn delivery will be ‘crucial’ for families.
Thanks to advances in imaging and diagnostic technologies, clinicians can now detect many genetic disorders in the womb, ...
Biohaven Ltd. (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range ...
The quality and quantity of RON95 petrol remain unchanged despite the subsidy targeting exercise under the Budi Madani RON95 ...
Q4 revenue -- $67.3 million reported for the quarter ended Dec. 31, 2025, compared to $1.5 million in Q4 2024; increase driven primarily by AstraZeneca and Gilead (NASDAQ:GILD) payments. Full-year ...
Planned submission for U.S. Accelerated Approval of z-rostudirsen on track for Q2 2026; potential launch in Q1 2027 - - Positive topline results reported from Phase 1/2 DELIVER trial of z-rostudirsen ...
A new study from researchers at Wake Forest University School of Medicine has identified a promising strategy to treat brain metastases, one of the most challenging and deadly complications of lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results